Elena Plessa

Elena Plessa

Auto-generated profile, based on publicly available information

Elena Plessa

Institute of Structural and Molecular Biology, University College London, London, UK

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2019 in RNA
Verified
Journal Article
Open access
PDF file
MSMaksim Svetlov
Maksim Svetlov
EPElena Plessa
Elena Plessa
CCChih-Wei Chen
Chih-Wei Chen
ABAnthony Bougas
Anthony Bougas
Marios KrokidisMarios Krokidis
Marios Krokidis
YPYury Polikanov
Yury Polikanov
The 70S ribosome is a major target for antibacterial drugs. Two of the classical antibiotics, chloramphenicol (CHL) and erythromycin (ERY), competitively bind to adjacent but separate sites on the bacterial ribosome: the catalytic peptidyl transferase center (PTC) and the nascent polypeptide exit tunnel (NPET), respectively. The previously reported competitive binding of CHL and ERY might be due either to a direct collision of the two drugs on the ribosome or due to a drug-induced allosteric effect. Because of the resolution limitations, the available structures of these antibiotics in complex with bacterial ribosomes do not allow us to discriminate between these two possible mechanisms. In this work, we have obtained two crystal structures of CHL and ERY in complex with the Thermus thermophilus 70S ribosome at a higher resolution (2.65 and 2.89 Å, respectively) allowing unambiguous placement of the drugs in the electron density maps. Our structures provide evidence of the direct collision of CHL and ERY on the ribosome, which rationalizes the observed competition between the two drugs.

8 November 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
EPElena Plessa
Elena Plessa
LCLien P. Chu
Lien P. Chu
SCSammy H. S. Chan
Sammy H. S. Chan
OTOliver L. Thomas
Oliver L. Thomas
ACAnaïs M. E. Cassaignau
Anaïs M. E. Cassaignau
LCLisa D. Cabrita
Lisa D. Cabrita
During biosynthesis, proteins can begin folding co-translationally to acquire their biologically-active structures. Folding, however, is an imperfect process and in many cases misfolding results in disease. Less is understood of how misfolding begins during biosynthesis. The human protein, alpha-1-antitrypsin (AAT) folds under kinetic control via a folding intermediate; its pathological variants readily form self-associated polymers at the site of synthesis, leading to alpha-1-antitrypsin deficiency. We observe that AAT nascent polypeptides stall during their biosynthesis, resulting in full-length nascent chains that remain bound to ribosome, forming a persistent ribosome-nascent chain complex (RNC) prior to release. We analyse the structure of these RNCs, which reveals compacted, partially-folded co-translational folding intermediates possessing molten-globule characteristics. We find that the highly-polymerogenic mutant, Z AAT, forms a distinct co-translational folding intermediate relative to wild-type. Its very modest structural differences suggests that the ribosome uniquely tempers the impact of deleterious mutations during nascent chain emergence. Following nascent chain release however, these co-translational folding intermediates guide post-translational folding outcomes thus suggesting that Z’s misfolding is initiated from co-translational structure. Our findings demonstrate that co-translational folding intermediates drive how some proteins fold under kinetic control, and may thus also serve as tractable therapeutic targets for human disease.

22 July 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
MAMinkoo Ahn
Minkoo Ahn
TWTomasz Włodarski
Tomasz Włodarski
AMAlkistis Mitropoulou
Alkistis Mitropoulou
SCSammy H. S. Chan
Sammy H. S. Chan
HSHaneesh Sidhu
Haneesh Sidhu
JCJohn Christodoulou
John Christodoulou
Co-translational folding is a fundamental process for the efficient biosynthesis of nascent polypeptides that emerge through the ribosome exit tunnel. To understand how this process is modulated by the shape and surface of the narrow tunnel, we have rationally engineered three exit tunnel protein loops (uL22, uL23 and uL24) of the 70S ribosome by CRISPR/Cas9 gene editing, and studied the co-translational folding of an immunoglobulin-like filamin domain (FLN5). Our thermodynamics measurements employing 19F/15N/methyl-TROSY NMR spectroscopy together with cryo-EM and molecular dynamics simulations reveal how the variations in the lengths of the loops present across species exert their distinct effects on the free energy of FLN5 folding. A concerted interplay of the uL23 and uL24 loops is sufficient to alter co-translational folding energetics, which we highlight by the opposite folding outcomes resulting from their extensions. These subtle modulations occur through a combination of the steric effects relating to the shape of the tunnel, the dynamic interactions between the ribosome surface and the unfolded nascent chain, and its altered exit pathway within the vestibule. These results illustrate the role of the exit tunnel structure in co-translational folding, and provide principles for how to remodel it to elicit a desired folding outcome.

16 September 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
MAMinkoo Ahn
Minkoo Ahn
TWTomasz Włodarski
Tomasz Włodarski
AMAlkistis Mitropoulou
Alkistis Mitropoulou
SCSammy H. S. Chan
Sammy H. S. Chan
HSHaneesh Sidhu
Haneesh Sidhu
JCJohn Christodoulou
John Christodoulou

26 April 2025 in bioRxiv
Verified
Preprint
Open access
EPElena Plessa
Elena Plessa
LCLien P. Chu
Lien P. Chu
CHCharity R. Hornby
Charity R. Hornby
JSJulian O. Streit
Julian O. Streit
AMAlkistis N. Mitropoulou
Alkistis N. Mitropoulou
LCLisa D. Cabrita
Lisa D. Cabrita
The majority of cellular proteins must adopt a particular three-dimensional structure for function 1 . However, protein folding is a perilous journey due to competing polypeptide misfolding events which result in inactive structures. In this study, we examine the earliest steps of protein misfolding during the biosynthesis of alpha-1-antitrypsin, a secreted plasma protein whose misfolding results in organ disease. Using human cells, we find that, like co-translational protein folding, misfolding, assembly and biosynthesis are interconnected processes. At the molecular level misfolding of alpha-1-antitrypsin is initiated by a molten globule-like folding intermediate formed cotranslationally on the ribosome. The ribosomal complexes subsequently form assemblies by recruiting released proteins, inducing translational arrest. Our data also reveal that a pharmacological chaperone modulates this process. The existence of co- and post-translational (mis)folding and assembly pathways reveals how some proteins form functional complexes, has implications for the pathogenesis of conformational diseases, and suggests novel therapeutic avenues.